Hatch-Waxman Act

Historically, the U.S. Food and Drug Administration has not exactly been a “speed demon” when it comes to approving new drugs. Thanks to the Generating Antibiotics Incentives Now (GAIN) Act and forward-thinking companies like Actavis plc (NYSE: ACT) that are taking advantage of that...